Much has been written about the biological false positive (BFP) reaction demonstrated by reagin tests applied to sera from patients suffering from leprosy. It is well known that a BFP reaction is in all but a very small minority of cases proved or disproved by recourse to specific tests for treponemal infection, i.e. the Treponema pallidum immobilization (TPI) test and/or the fluorescent treponemal antibody absorption (FTA-ABS) test The FTA-ABS test is not as specific as the TPI test and therefore not as well fitted for demonstration of BFP sera as the TPI test (Fribourg-Blanc and Niel, 1967) . The TPI test, still the most specific serological test for the diagnosis of treponemal infection (Wilkinson and Rayner, 1966) (Table II) .
Non-specific reactive results to the RPCF test were given by two sera only, both being from male patients aged 19 and 30 years in the leprosarium. One serum was reactive to the RPCF test only and the other was reactive to the RPCF and VDRL tests only. Both these sera gave non-reactive results to the TPI and FTA-ABS tests (Table II) .
Sera from eleven patients were reactive to the FTA-200 test but non-reactive to the TPI and FTA-ABS tests. Of these eleven sera, two were also reactive to the VDRL test; these sera were from a female aged 41 years and a male aged 37 years, both at the leprosarium. Of the remaining nine sera, two were from males aged 30 and 31 years attending the skin clinic and seven from patients at the leprosarium (two females aged 22 and 38 years and five males aged 17 to 37 years). The results with the eleven sera in this group were regarded as non-specific reactions to the FTA-200 test (Table II) .
The TPI test was non-reactive and the FTA-ABS test reactive with sera from two patients; one from a male aged 34 years was reactive to the FTA-ABS test only and the other from a male aged 29 years was reactive to both the VDRL and FTA-ABS tests (Table III) . 
Discussion
It is an accepted fact that leprosy and treponemal infection can co-exist and that the prevalence of treponemal infection in lepers is similar to that in the population from which they are drawn. In this survey a reactive TPI test result has been Thus the prevalence of treponemal infection among the leprosy patients was probably not a true indication of prevalence in the copimunity as a whole because of variation in socio-economic background, chance of exposure to treponemal infection, e.g. yaws, and the unequal grouping together of patients in a leprosarium compared with their normal spread through the community as a whole. There was complete agreement between the results of the TPI and FTA-ABS tests in this group of leprosy patients.
Leprosy, especially the lepromatous form, is well known to be associated with BFP reactions. In our group, sera from 22 out of 270 patients with lepromatous leprosy (8-1 per cent.) showed BFP reactions, i.e. reactive results to reagin detection tests and non-reactive results to treponemal tests. These reactions were commoner in females (12 of 67) than in males (10 of 203) in the leprosy group.
The incidence of reported BFP results in sera from leprosy patients has varied greatly. Nelson (1952) (Table I) .
That the VDRL test among the two reagin tests was reactive in all sera except two in Table I Kiraly, Jobbagy, and Kovats (1967) showed that the Reiter treponeme alone did not always remove all group antibody from all sera. As a result of this work it is felt that a reactive FTA-ABS test, when all other tests (i.e. CWR, VDRL, RPCF, and TPI test) are non-reactive, must be viewed with caution.
The order of percentage agreement of each test in relation to negative results to the TPI test in the leprosy sera listed in Tables II and III and the  218 Table I , the TPI, FTA-200, and FTA-ABS tests were of equal sensitivity, followed by the VDRL test (13 of 15), the RPCF test (7 of 15), and finally the CWR (5 of 15). These findings are summarized in Table IV (overleaf). This overall pattern of specificity and sensitivity of the FTA-ABS test on sera from patients with lepromatous leprosy indicates that it is able to replace the TPI test in detecting BFP reactions and non-specific positive results to tests for treponemal 
